Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,754.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 65,535
  • Market Cap: £1,811.41m
  • RiskGrade: 128

Income Statement - Unadjusted

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
30-Jun-21 30-Jun-20 30-Jun-19 30-Jun-15 30-Jun-14
Continuing Operations          
Revenue 574.30 551.40 488.50 398.50 372.20
           
EBITDA 37.10 32.90 35.00 72.80 53.30
Depreciation & Amortisation (24.00) (24.00) (26.30) (13.30) (11.50)
           
Operating Profit/(Loss) 13.10 8.90 8.70 59.50 41.80
Interest Payable (5.40) (5.30) (4.70) (4.80) (5.70)
Interest Receivable/Investment Income 0.40 0.30 0.80 0.20 0.20
           
Group Profit after Interest 8.10 3.90 4.80 54.90 36.30
Share of Assoc Cos/JV Profits 47.70 42.40 5.10 2.90 1.90
           
Profit Before Tax 55.80 46.30 9.90 57.80 38.20
Tax (9.00) (10.60) (3.20) (17.30) (9.30)
           
Profit After Tax 46.80 35.70 6.70 40.50 28.90
           
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
           
PROFIT FOR THE PERIOD 46.80 35.70 6.70 40.50 28.90
           
Attributable to:          
Equity Shareholders' Earnings 47.30 35.30 7.80 39.90 28.90
Minority interests (0.50) 0.40 (1.10) 0.60 n/a
           
Equity Dividends cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year cn/a cn/a cn/a cn/a cn/a


Per Share Record - Unadjusted 30-Jun-21 30-Jun-20 30-Jun-19 30-Jun-15 30-Jun-14
Continuing EPS          
Earnings per Share - Basic 72.60p 54.40p 12.40p 65.70p 47.70p
Earnings per Share - Diluted 72.00p 54.00p 11.90p 64.90p 47.60p
Continuing and Discontinued EPS          
Earnings per Share - Basic 72.60p 54.40p 12.40p 65.70p 47.70p
Earnings per Share - Diluted 72.00p 54.00p 11.90p 64.90p 47.60p
           
Dividend per Share 32.00p 29.10p 27.70p 19.50p 17.70p


Key Financals 30-Jun-21 30-Jun-20 30-Jun-19 30-Jun-15 30-Jun-14
Shares in Issue (millions)          
Shares in Issue - Year End 65.76 65.09 65.05 60.73 60.68
Weighted Average 65.11 64.91 63.14 60.70 60.59
Diluted 65.66 65.43 65.30 61.48 60.71
           
Performance Ratios          
Continuing Operations          
Operating Margin 2.28% 1.61% 1.78% 14.93% 11.23%
Tax Rate 148.15% 330.77% 66.67% 31.51% 25.62%
Return on Capital Employed 0.11% 9.37% 0.71% 17.35% 13.32%
Continuing Operations & Discontinued Operations          
Return on Equity (ROE) 0.08% 6.16% 0.35% 9.59% 7.71%
           
Financial Status          
Continuing Operations          
Interest Cover 11.33 9.74 3.11 13.04 7.70
Revenue per Share 8.90p 849.51p 193.28p 656.49p 614.27p
Pre-Tax Profit per Share 0.86p 71.33p 3.92p 95.22p 63.05p
           
Market Data          
Continuing Operations          
Earnings per Share Growth - Basic 34% 339% -81% 38% 23%
Earnings per Share Growth - Adjusted 30% 6% 29% 22% -5%
Earnings per Share Growth - Diluted 33% 354% -82% 36% 24%
PE Ratio - Adjusted 49.2 45.7 36.2 25.1 24.7
PEG - Adjusted 1.6 7.6 1.2 1.1 n/a
Dividend Cover 3.15 2.66 2.64 2.91 2.63
Continuing Operations & Discontinued Operations          
Earnings per Share Growth - Basic -99% 1,656% -95% 38% 23%
Earnings per Share Growth - Adjusted -99% 323% -68% 22% -5%
Earnings per Share Growth - Diluted -99% 1,716% -95% 36% 24%
PE Ratio - Adjusted 4,870.0 45.7 144.8 25.1 24.7
PEG - Adjusted n/a 0.1 n/a 1.1 n/a
Dividend Cover 0.03 2.66 0.66 2.91 2.63
           
Market Capitalisation £ (Millions) 3,261.77 2,299.04 1,722.64 866.61 696.00
Dividend per Share 32.00p 29.10p 27.70p 19.50p 17.70p
Dividend Yield 0.6% 0.8% 1.0% 1.4% 1.5%
Dividend per Share Growth 9.97% 5.05% 42.05% 10.17% 9.94%

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page